Skip to main content
Top
Published in: Acta Diabetologica 4/2013

01-08-2013 | Original Article

Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: the di@bet.es study

Authors: Clara Marcuello, Alfonso L. Calle-Pascual, Manuel Fuentes, Isabelle Runkle, Miguel A. Rubio, Carmen Montañez, Gemma Rojo-Martinez, Federico Soriguer, Elena Bordiu, Albert Goday, Anna Bosch-Comas, Rafael Carmena, Roser Casamitjana, Luis Castaño, Conxa Castell, Miguel Catalá, Elias Delgado, Josep Franch, Sonia Gaztambide, Juan Girbés, Ramon Gomis, Ines Urrutia, Alfonso López-Alba, Maria T. Martínez-Larrad, Eldelmiro Menéndez, Inmaculada Mora-Peces, Emilio Ortega, Gemma Pascual-Manich, Manuel Serrano-Rios, Sergio Valdés, Jose A. Vázquez, Joan Vendrell

Published in: Acta Diabetologica | Issue 4/2013

Login to get access

Abstract

The aim of the study is to assess the prevalence of metabolic syndrome (MetS) in Spain using specific cutoff points for waist circumference (WC) (>94.5 cm for men and >89.5 cm for women) and evaluating the influence of several socio-demographic and economic factors. Data on MetS were obtained from a national study of 4,727 subjects from 18 to 90 years of age, conducted in Spain between 2009 and 2010 (The di@bet.es study). MetS was defined applying the new Harmonized definition (evaluating the use of abdominal obesity (AO) as a obligatory criterion for MetS or not) as well as with other widely used criteria. Results were then compared with data from previous studies. Multiple logistic regression models were used to evaluate the influence of different social factors. The age-standardized MetS prevalence was 38.37 % (CI 35.74–40.99) in men and 29.62 % (CI 27.56–31.69) in women, when AO was required as a diagnostic criterion; 42.13 % (CI 39.37–44.89) and 32.31 % (CI 30.15–34.47) in men and women, respectively, if AO was not considered mandatory. Prevalence of MetS increased with age (p < 0.001 for trend). Women with a lower educational level were more likely to have MetS (OR 4.4; 95 % CI: 2.84-6.7) as compared with those with a higher educational level. Subjects with MetS had a worse physical quality of life. The combination of AO, hypertension and carbohydrate alterations was the most common MetS’ pattern. A high prevalence of MetS was detected in the Spanish population especially in men, the elderly and women with a low educational level.
Literature
1.
go back to reference Fernádez-Bergés D, Cabrera de León A, Sanz H, Elosua R, Guembe MJ, Alzamora M, Vega-Alonso T, Félix-Redondo FJ, Ortiz-Marrón H, Rigo F, Lama C, Gavrila D, Segura-Fragoso A, Lozano L, Marrugat J (2012) Metabolic syndrome in Spain: prevalence and coronary risk associated with harmonized definition and WHO proposal. DARIOS study. Rev Esp Cardiol 65:241–248 Fernádez-Bergés D, Cabrera de León A, Sanz H, Elosua R, Guembe MJ, Alzamora M, Vega-Alonso T, Félix-Redondo FJ, Ortiz-Marrón H, Rigo F, Lama C, Gavrila D, Segura-Fragoso A, Lozano L, Marrugat J (2012) Metabolic syndrome in Spain: prevalence and coronary risk associated with harmonized definition and WHO proposal. DARIOS study. Rev Esp Cardiol 65:241–248
3.
go back to reference Lean ME, Han TS, Morrison CE (1995) Waist circumference as a measure for indicating need for weight management. BMJ 311:158–161PubMedCrossRef Lean ME, Han TS, Morrison CE (1995) Waist circumference as a measure for indicating need for weight management. BMJ 311:158–161PubMedCrossRef
4.
go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645 Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645
5.
go back to reference Martínez-Larrad MT, Fernández-Pérez C, Corbatón-Anchuelo A, Gabriel R, Lorenzo C, Serrano-Ríos M (2011) Revised waist circumference cut-off points for the criteria of abdominal obesity in the Spanish population: multicenter nationwide Spanish population based study. Av Diabetol 27:168–174CrossRef Martínez-Larrad MT, Fernández-Pérez C, Corbatón-Anchuelo A, Gabriel R, Lorenzo C, Serrano-Ríos M (2011) Revised waist circumference cut-off points for the criteria of abdominal obesity in the Spanish population: multicenter nationwide Spanish population based study. Av Diabetol 27:168–174CrossRef
6.
go back to reference Hara K, Matsushita Y, Horikoshi M, Yoshiike N, Yokoyama T, Tanaka H, Kadowaki T (2006) A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care 29:1123–1124PubMedCrossRef Hara K, Matsushita Y, Horikoshi M, Yoshiike N, Yokoyama T, Tanaka H, Kadowaki T (2006) A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care 29:1123–1124PubMedCrossRef
7.
go back to reference Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R (2009) First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 32:1092–1097PubMedCrossRef Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R (2009) First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 32:1092–1097PubMedCrossRef
8.
go back to reference Alegría E, Cordero A, Laclaustra M, Grima A, León M, Casasnovas JA, Luengo E, del Río A, Ferreira I (2005) Investigadores del registro MESYAS. Prevalence of metabolic syndrome in the Spanish working population: mESYAS registry. Rev Esp Cardiol 58:797–806PubMedCrossRef Alegría E, Cordero A, Laclaustra M, Grima A, León M, Casasnovas JA, Luengo E, del Río A, Ferreira I (2005) Investigadores del registro MESYAS. Prevalence of metabolic syndrome in the Spanish working population: mESYAS registry. Rev Esp Cardiol 58:797–806PubMedCrossRef
9.
go back to reference Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, Casamitjana R, Castaño L, Castell C, Catalá M, Delgado E, Franch J, Gaztambide S, Girbés J, Gomis R, Gutiérrez G, López-Alba A, Martínez-Larrad MT, Menéndez E, Mora-Peces I, Ortega E, Pascual-Manich G, Rojo-Martínez G, Serrano-Rios M, Valdés S, Vázquez JA, Vendrell J (2012) Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the di@bet.es study. Diabetologia 55:88–93PubMedCrossRef Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, Casamitjana R, Castaño L, Castell C, Catalá M, Delgado E, Franch J, Gaztambide S, Girbés J, Gomis R, Gutiérrez G, López-Alba A, Martínez-Larrad MT, Menéndez E, Mora-Peces I, Ortega E, Pascual-Manich G, Rojo-Martínez G, Serrano-Rios M, Valdés S, Vázquez JA, Vendrell J (2012) Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the di@bet.es study. Diabetologia 55:88–93PubMedCrossRef
10.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association, National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752PubMedCrossRef Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association, National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752PubMedCrossRef
11.
go back to reference Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome-a new worldwide definition. Lancet 366:1059PubMedCrossRef Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome-a new worldwide definition. Lancet 366:1059PubMedCrossRef
12.
go back to reference Vilagut G, Valderas JM, Feerer M, Garin O, López García E, Alonso J (2008) Interpretation of SF-36 and SF-12 questionnaires in Spain: physical and mental components. Med Clin (Barc) 130:726–735CrossRef Vilagut G, Valderas JM, Feerer M, Garin O, López García E, Alonso J (2008) Interpretation of SF-36 and SF-12 questionnaires in Spain: physical and mental components. Med Clin (Barc) 130:726–735CrossRef
14.
go back to reference Cameron AJ, Shaw JE, Zimmet PZ (2004) The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 33:351–375PubMedCrossRef Cameron AJ, Shaw JE, Zimmet PZ (2004) The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 33:351–375PubMedCrossRef
15.
go back to reference Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, DECODE Study Group (2004) Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164:1066–1076PubMedCrossRef Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, DECODE Study Group (2004) Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164:1066–1076PubMedCrossRef
16.
go back to reference Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359PubMedCrossRef Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359PubMedCrossRef
17.
go back to reference Ford ES, Giles WH, Mokdad AH (2004) Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 27:2444–2449PubMedCrossRef Ford ES, Giles WH, Mokdad AH (2004) Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 27:2444–2449PubMedCrossRef
18.
go back to reference Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA (2007) Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 7:220. doi:10.1186/1471-2458-7-220. Accessed 1st Sept 2012 Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA (2007) Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 7:220. doi:10.​1186/​1471-2458-7-220. Accessed 1st Sept 2012
19.
go back to reference Ford ES, Li C, Zhao G (2010) Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes 2:180–193PubMedCrossRef Ford ES, Li C, Zhao G (2010) Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes 2:180–193PubMedCrossRef
20.
go back to reference Gutiérrez-Fisac JL, Guallar-Castillón P, León-Muñoz LM, Graciani A, Banegas JR, Rodríguez-Artalejo F (2012) Prevalence of general and abdominal obesity in the adult population of Spain, 2008–2010: the ENRICA study. Obes Rev 13:388–392PubMedCrossRef Gutiérrez-Fisac JL, Guallar-Castillón P, León-Muñoz LM, Graciani A, Banegas JR, Rodríguez-Artalejo F (2012) Prevalence of general and abdominal obesity in the adult population of Spain, 2008–2010: the ENRICA study. Obes Rev 13:388–392PubMedCrossRef
21.
go back to reference Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M, Alberti KG (1997) Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II Study. Diabetologia 40:1341–1349PubMedCrossRef Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M, Alberti KG (1997) Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II Study. Diabetologia 40:1341–1349PubMedCrossRef
22.
go back to reference Silventoinen K, Pankow J, Jousilahti P, Hu G, Tuomilehto J (2005) Educational inequalities in the metabolic syndrome and coronary heart disease among middle-aged men and women. Int J Epidemiol 34:327–334PubMedCrossRef Silventoinen K, Pankow J, Jousilahti P, Hu G, Tuomilehto J (2005) Educational inequalities in the metabolic syndrome and coronary heart disease among middle-aged men and women. Int J Epidemiol 34:327–334PubMedCrossRef
23.
go back to reference Park SJ, Kang HT, Nam CM, Park BJ, Linton JA, Lee YJ (2012) Sex differences in the relationship between socioeconomic status and metabolic syndrome: the Korean National Health and Nutrition Examination Survey. Diabetes Res Clin Pract 96:400–406PubMedCrossRef Park SJ, Kang HT, Nam CM, Park BJ, Linton JA, Lee YJ (2012) Sex differences in the relationship between socioeconomic status and metabolic syndrome: the Korean National Health and Nutrition Examination Survey. Diabetes Res Clin Pract 96:400–406PubMedCrossRef
24.
go back to reference Martínez-Larrad MT, Fernández-Pérez C, González-Sánchez JL, López A, Fernández-Alvarez J, Riviriego J, Serrano-Ríos M, Grupo de Estudio de Atención Primaria de Segovia (2005) Prevalencia del síndrome metabólico (criterios del ATP III). Estudio de base poblacional en áreas rural y urbana de la provincia de Segovia. Med Clin (Barc) 125:481–486CrossRef Martínez-Larrad MT, Fernández-Pérez C, González-Sánchez JL, López A, Fernández-Alvarez J, Riviriego J, Serrano-Ríos M, Grupo de Estudio de Atención Primaria de Segovia (2005) Prevalencia del síndrome metabólico (criterios del ATP III). Estudio de base poblacional en áreas rural y urbana de la provincia de Segovia. Med Clin (Barc) 125:481–486CrossRef
25.
go back to reference Calbo Mayo JM, Terrancle de Juan I, Fernández Jiménez P, Rodríguez Martín MJ, Martínez Díaz V, Santisteban López Y, Navarro Martínez A, Sáez Méndez L, Gómez Garrido J, Moreno Salcedo J, Vera Hernández J, Fuster Lluch O, Beato JL, Bleda JM, Solera Santos J, Grupo de Estudio Síndrome Metabólico de Albacete (2007) Prevalencia del síndrome metabólico en la provincia de Albacete. Rev Clin Esp 207:64–88 Calbo Mayo JM, Terrancle de Juan I, Fernández Jiménez P, Rodríguez Martín MJ, Martínez Díaz V, Santisteban López Y, Navarro Martínez A, Sáez Méndez L, Gómez Garrido J, Moreno Salcedo J, Vera Hernández J, Fuster Lluch O, Beato JL, Bleda JM, Solera Santos J, Grupo de Estudio Síndrome Metabólico de Albacete (2007) Prevalencia del síndrome metabólico en la provincia de Albacete. Rev Clin Esp 207:64–88
26.
go back to reference Lim H, Nguyen T, Choue R, Wang Y (2012) Sociodemographic disparities in the composition of metabolic syndrome components among adults in South Korea. Diabetes Care 35:2028–2035PubMedCrossRef Lim H, Nguyen T, Choue R, Wang Y (2012) Sociodemographic disparities in the composition of metabolic syndrome components among adults in South Korea. Diabetes Care 35:2028–2035PubMedCrossRef
27.
go back to reference Márquez-Sandoval F, Macedo-Ojeda G, Viramontes-Hörner D, Fernández Ballart JD, Salas Salvadó J, Vizmanos B (2011) The prevalence of metabolic syndrome in Latin America: a systematic review. Public Health Nutr 14:1702–1713PubMedCrossRef Márquez-Sandoval F, Macedo-Ojeda G, Viramontes-Hörner D, Fernández Ballart JD, Salas Salvadó J, Vizmanos B (2011) The prevalence of metabolic syndrome in Latin America: a systematic review. Public Health Nutr 14:1702–1713PubMedCrossRef
28.
go back to reference Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB (2011) The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 57:1299–1313PubMedCrossRef Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB (2011) The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 57:1299–1313PubMedCrossRef
29.
go back to reference Alexander CM, Landsman PB, Grundy SM (2008) The influence of age and body mass index on the metabolic syndrome and its components. Diabetes Obes Metab 10:246–250PubMedCrossRef Alexander CM, Landsman PB, Grundy SM (2008) The influence of age and body mass index on the metabolic syndrome and its components. Diabetes Obes Metab 10:246–250PubMedCrossRef
31.
go back to reference Miettola J, Niskanen LK, Viinamäki H, Sintonen H, Kumpusalo E (2008) Metabolic syndrome is associated with impaired health-related quality of life: Lapinlahti 2005 study. Qual Life Res 17:1055–1062PubMedCrossRef Miettola J, Niskanen LK, Viinamäki H, Sintonen H, Kumpusalo E (2008) Metabolic syndrome is associated with impaired health-related quality of life: Lapinlahti 2005 study. Qual Life Res 17:1055–1062PubMedCrossRef
32.
go back to reference Schlotz W, Ambery P, Syddall HE, Crozier SR, Sayer AA, Cooper C, Phillips DI, Hertfordshire Cohort Study Group (2007) Specific associations of insulin resistance with impaired health-related quality of life in the Hertfordshire Cohort Study. Qual Life Res 16:429–436PubMedCrossRef Schlotz W, Ambery P, Syddall HE, Crozier SR, Sayer AA, Cooper C, Phillips DI, Hertfordshire Cohort Study Group (2007) Specific associations of insulin resistance with impaired health-related quality of life in the Hertfordshire Cohort Study. Qual Life Res 16:429–436PubMedCrossRef
33.
go back to reference Tziallas D, Kastanioti C, Kostapanos MS, Skapinakis P, Elisaf MS, Mavreas V (2012) The impact of the metabolic syndrome on health-related quality of life: a cross-sectional study in Greece. Eur J Cardiovasc Nurs 11:297–303PubMed Tziallas D, Kastanioti C, Kostapanos MS, Skapinakis P, Elisaf MS, Mavreas V (2012) The impact of the metabolic syndrome on health-related quality of life: a cross-sectional study in Greece. Eur J Cardiovasc Nurs 11:297–303PubMed
34.
go back to reference Blüher M (2012) Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 19:341–346PubMedCrossRef Blüher M (2012) Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 19:341–346PubMedCrossRef
35.
go back to reference Neira M, de Onis M (2006) The Spanish strategy for nutrition, physical activity and the prevention of obesity. Br J Nutr 96(Suppl 1):S8–S11PubMedCrossRef Neira M, de Onis M (2006) The Spanish strategy for nutrition, physical activity and the prevention of obesity. Br J Nutr 96(Suppl 1):S8–S11PubMedCrossRef
Metadata
Title
Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: the di@bet.es study
Authors
Clara Marcuello
Alfonso L. Calle-Pascual
Manuel Fuentes
Isabelle Runkle
Miguel A. Rubio
Carmen Montañez
Gemma Rojo-Martinez
Federico Soriguer
Elena Bordiu
Albert Goday
Anna Bosch-Comas
Rafael Carmena
Roser Casamitjana
Luis Castaño
Conxa Castell
Miguel Catalá
Elias Delgado
Josep Franch
Sonia Gaztambide
Juan Girbés
Ramon Gomis
Ines Urrutia
Alfonso López-Alba
Maria T. Martínez-Larrad
Eldelmiro Menéndez
Inmaculada Mora-Peces
Emilio Ortega
Gemma Pascual-Manich
Manuel Serrano-Rios
Sergio Valdés
Jose A. Vázquez
Joan Vendrell
Publication date
01-08-2013
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 4/2013
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-013-0468-8

Other articles of this Issue 4/2013

Acta Diabetologica 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine